Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1Phase EARLY_PHASE1 1

Status

Completed 24Unknown 10Recruiting 7Withdrawn 4Terminated 4Active not recruiting 3Not yet recruiting 2

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Plasma cell 1Lymphoid 1CNS 1Breast 1

Conditions

Waldenstrom Macroglobulinemia 1Multiple Myeloma 1Hemangioma, Cavernous, Central Nervous System 1Breast Neoplasms 1

Interventions

Cyclophosphamide 241Radiotherapy 217Gemcitabine 187Cisplatin 185Carboplatin 182Docetaxel 166Bevacizumab 166Paclitaxel 144Capecitabine 142Rituximab 141pembrolizumab 140Nivolumab 126Oxaliplatin 124Dexamethasone 122Fluorouracil 113fludarabine 104Radiosurgery 101Doxorubicin 99fludarabine phosphate 97Irinotecan 96Etoposide 95Lenalidomide 93Cytarabine 92Magnetic Resonance Spectroscopy 90Radiation 89Filgrastim 89Leucovorin 88Bortezomib 86Cetuximab 80Pemetrexed 79

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Terminated × OTHER × Simvastatin × Clear all
NCT02096588 2024-07-09

Detection and Prevention of Anthracycline-Related Cardiac Toxicity With Concurrent Simvastatin

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Terminated
34 enrolled 11 charts
Breast

Breast Neoplasms

NCT01764451 2024-03-12

Permeability MRI in Cerebral Cavernous Malformations Type 1 in New Mexico: Effects of Statins

University of New Mexico

Phase EARLY_PHASE1 Terminated
12 enrolled
CNS

Hemangioma, Cavernous, Central Nervous System

NCT01772719 2019-11-18

Overcoming Chemotherapy Resistance In Refractory Multiple Myeloma With Simvastatin and Zoledronic Acid

University of Louisville

Phase NA Terminated
7 enrolled 4 charts
Plasma cell

Multiple Myeloma

NCT00575965 2015-12-16

Simvastatin in Waldenstrom's Macroglobulinemia

Dana-Farber Cancer Institute

Phase 2 Terminated
18 enrolled 5 charts
Lymphoid

Waldenstrom Macroglobulinemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡